fbpx
Knowledge is the first and last step to investing

AstraZeneca and Daiichi Sankyo’s Enhertu becomes the first drug of its kind granted approval to treat tumors anywhere in the body if patients test positive for a protein known to speed up cancer growth.

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?